Company Name: QT VASCULAR LTD.
Research House: UOB KayHian | Price Call: BUY | Target Price: 0.60 |
SINGAPORE (Feb 26): UOB Kay Hian has maintained its "buy" rating for QT Vascular, the designer and distributor of medical devices for vascular diseases, with a target price of 60 cents, as its FY14 results came in within expectations.
FY14 revenue rose 140.7% yoy to US$13.2 million ($17.9 million), compared with UOB Kay Hian estimates of US$13.4 million, driven by higher sales volumes of the Chocolate PTA and Glider PTCA balloon catheters in the US.
No comments:
Post a Comment